These include models such as 5xFAD and 3xTg-AD mice, which carry human mutations that promote AD pathology through mechanisms like Aβ plaque deposition (e.g., in APP/PS1 and 5xFAD) or combined amyloid and tau pathology (as seen in 3xTg-AD) [28]. This evidence concerns the gene MAPT and Alzheimer disease.